Pharmaceutical company
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies. Proposals on patent policy impacting biopharmaceutical innovation.
HCR - Health Issues CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
VENN STRATEGIES
1341 G Street NW, 6th Floor, WASHINGTON, DC, 20005, US
MICHAEL SPIRA SAMUEL GOODSTEIN SAMUEL GOODSTEIN MICHAEL SPIRA